- Zacks•last month
Nymox (NYMX) announced positive results from the seven-year, prospective, placebo-controlled, double-blind study on fexapotide (NX-1207).
- Insider Monkey•last month
In a marked reversal, crude futures are off 1.4% today after a disappointing EIA report, while the broader indexes are each higher as traders await the ‘Brexit’ outcome tomorrow. Among the stocks showing more volatility than the indexes are MBIA Inc. (NYSE:MBI), Emergent Biosolutions Inc (NYSE:EBS), Inovio Pharmaceuticals Inc (NASDAQ:INO), Fitbit Inc (NYSE:FIT), and Nymox Pharmaceutical Corporation […]
Nymox Pharmaceutical CorporationNasdaqCM
|Bid||3.63 x 100|
|Ask||10.24 x 4500|
|52wk Range||1.79 - 4.37|
|Day's Range||3.65 - 4.00|
|Avg Vol (3m)||250,814|
As of 4:00 PM EDT. Market closed.